CliniMACS® CD34+ Reagent System for Expanded Access Use

Clinical trial NCT02026934 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT02026934
Sponsor: Joseph Antin
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Graft-Versus-Host Disease(GVHD)Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells Graft Failure Delayed Graft Function

Start date: 2013-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.